Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis

Autoimmunity Reviews

Volumn 12, Issue 4, 2013, Pages 477-482

  Sinico, Renato A ^a   Di Toma, Luca ^b   Radice, Antonella ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b Ospedale Civile di Legnano   (Italy)

Author keywords

ANCA; Churg Strauss syndrome; Microscopic polyangiitis; Necrotizing and crescentic glomerulonephritis; Vasculitis; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; RITUXIMAB;

ANCA ASSOCIATED RENAL VASCULITIS; ANCA ASSOCIATED VASCULITIS; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DETERIORATION; DISEASE EXACERBATION; END STAGE RENAL DISEASE; FERTILITY; GLOMERULOSCLEROSIS; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; MAINTENANCE THERAPY; MICROSCOPIC POLYANGIITIS; OUTCOME ASSESSMENT; PATHOLOGY; PLASMAPHERESIS; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RELAPSE; REMISSION; REVIEW; WEGENER GRANULOMATOSIS; GLOMERULONEPHRITIS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHURG-STRAUSS SYNDROME; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; PROGNOSIS;

MLCS; MLOWN;

EID: 84880641104     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.08.006     Document Type: Review

References (59)

1. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
2. Jennette J.C., Falk R.J. Small-vessel vasculitis. N Engl J Med 1997, 337:1512-1523.
3. Savage C.O., Harper L., Adu D. Primary systemic vasculitis. Lancet 1997, 349:553-558.
4. Sinico R.A., Di Toma L., Maggiore U., Tosoni C., Bottero P., Sabadini E., et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 2006, 47(5):770-779.
5. Pagnoux C., Guilpain P., Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007, 19(1):25-32.
6. Sinico R.A., Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol 2009, 23(3):355-366.
7. Holle J.U., Laudien M., Gross W.L. Clinical manifestations and treatment of Wegener's granulomatosis. Rheum Dis Clin North Am 2010, 36(3):507-526.
8. Schilder A.M. Wegener's granulomatosis vasculitis and granuloma. Autoimmun Rev 2010, 9(7):483-487.
9. Falk R.J., Gross W.L., Guillevin L., Hoffman G.S., Jayne D.R., Jennette J.C., et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum Apr 2011, 63(4):863-864.
10. Villiger P.M., Guillevin L. Microscopic polyangiitis: clinical presentation. Autoimmun Rev 2010, 9(12):812-819.
11. Lee R.W., D'Cruz D.P. Pulmonary renal vasculitis syndromes. Autoimmun Rev 2010, 9(10):657-660.
12. Schena F.P. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol Dial Transplant 1997, 12(3):418-426.
13. Mukhtyar C., Flossmann O., Hellmich B., Bacon P., Cid M., Cohen-Tervaert J.W., et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008, 67(7):1004-1010.
14. Flossmann O., Berden A., de Groot K., Hagen C., Harper L., Heijl C., et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011, 70(3):488-494.
15. Little M.A., Pusey C.D. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 2004, 17(Suppl. 8):10-19.
16. Hedger N., Stevens J., Drey N., Walker S., Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant 2000, 15(10):1593-1599.
17. D'Amico G., Sinico R.A., Ferrario F. Renal vasculitis. Nephrol Dial Transplant 1996, 11(S9):69-74.
18. Rutgers A., Sanders J.S., Stegeman C.A., Kallenberg C.G. Pauci-immune necrotizing glomerulonephritis. Rheum Dis Clin North Am 2010, 36(3):559-572.
19. Berden A.E., Ferrario F., Hagen E.C., Jayne D.R., Jennette J.C., Joh K., et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010, 21(10):1628-1636.
20. Bajema I.M. Pathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Clin Exp Immunol 2011, 164(Suppl. 1):14-16.
21. Hauer H.A., Bajema I.M., Van Houwelingen H.C., Ferrario F., Noël L.H., Waldherr R., et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002, 62(5):1732-1742.
22. Day C.J., Howie A.J., Nightingale P., Shabir S., Adu D., Savage C.O., et al. Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis 2010, 55(2):250-258.
23. Neumann I., Regele H., Kain R., Birck R., Meisl F.T. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2003, 18(3):524-531.
24. Haas M., Eustace J.A. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004, 65(6):2145-2152.
25. de Lind van Wijngaarden R.A., Hauer H.A., Wolterbeek R., Jayne D.R., Gaskin G., Rasmussen N., et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006, 17(8):2264-2274.
26. Hogan S.L., Falk R.J., Chin H., Cai J., Jennette C.E., Jennette J.C., et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005, 143(9):621-631.
27. Sinico R.A., D'Amico G. Renal involvement in primary vasculitides. Clin Rev Allergy Immunol 1997, 15(1):65-72.
28. Kallenberg C.G., Brouwer E., Weening J.J., Tervaert J.W. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994, 46:1-15.
29. Hagen E.C., Daha M.R., Hermans J., Andrassy K., Csernok E., Gaskin G., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR project for ANCA assay standardization. Kidney Int 1998, 53(3):743-753.
30. Radice A., Sinico R.A. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005, 38(1):93-103.
31. Vaglio A., Casazza I., Grasselli C., Corradi D., Sinico R.A., Buzio C. Churg-Strauss syndrome. Kidney Int 2009, 76(9):1006-1011.
32. Sinico R.A., Di Toma L., Maggiore U., Bottero P., Radice A., Tosoni C., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005, 52:2926-2935.
33. Sable-Fourtassou R., Cohen P., Mahr A., Pagnoux C., Mouthon L., Jayne D., et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005, 143:632-638.
34. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999, 78:26-37.
35. Richer C., Mouthon L., Cohen P., Buchet P., Royer I., Guettier C., et al. IgA glomerulonephritis associated with microscopic polyangiitis or Churg-Strauss syndrome. Clin Nephrol 1999, 52(1):47-50.
36. De Stefano R., Frati E., Brugnano R., Covarelli C., Pittavini L., Sidoni A. IgA glomerulonephritis associated with Churg-Strauss syndrome. Clin Exp Rheumatol 2011, 29(1 Suppl. 64):S141-S142.
37. Rich L.M., Piering W.F. Ureteral stenosis due to recurrent Wegener's granulomatosis after kidney transplantation. J Am Soc Nephrol 1994, 4(8):1516-1521.
38. Wen Y.K., Chen M.L. Microscopic polyangiitis atypically presenting with tubulointerstitial nephritis. Clin Nephrol 2006, 65(5):356-360.
39. Tamei N., Sugiura H., Takei T., Itabashi M., Uchida K., Nitta K. Ruptured arterial aneurysm of the kidney in a patient with microscopic polyangiitis. Intern Med 2008, 47(6):521-526.
40. Senf R., Jürgensen J.S., Teichgräber U., Kampf D., Schindler R. Ruptured arterial aneurysm of the kidney in a patient with Wegener's granulomatosis. Nephrol Dial Transplant 2003, 18(12):2671-2673.
41. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68(3):310-317.
42. Carruthers D., Sherlock J. Evidence-based management of ANCA vasculitis. Best Pract Res Clin Rheumatol 2009, 23(3):367-378.
43. Jayne D., Rasmussen N., Andrassy K., Bacon P., Tervaert J.W., Dadoniené J., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349(1):36-44.
44. Jayne D.R., Gaskin G., Rasmussen N., Abramowicz D., Ferrario F., Guillevin L., et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007, 18(7):2180-2188.
45. de Groot K., Harper L., Jayne D.R., Flores Suarez L.F., Gregorini G., Gross W.L., et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009, 150(10):670-680.
46. de Groot K., Adu D., Savage C.O., EUVAS (European vasculitis study group) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001 Oct, 16(10):2018-2027.
47. Hiemstra T.F., Walsh M., Mahr A., Savage C.O., de Groot K., Harper L., et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 2010, 304(21):2381-2388.
48. Pagnoux C., Mahr A., Hamidou M.A., Boffa J.J., Ruivard M., Ducroix J.P., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359(26):2790-2803.
49. Walsh M., Catapano F., Szpirt W., Thorlund K., Bruchfeld A., Guillevin L., et al. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 2011, 57(4):566-574.
50. Jones R.B., Ferraro A.J., Chaudhry A.N., Brogan P., Salama A.D., Smith K.G., et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60(7):2156-2168.
51. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
52. Jones R.B., Tervaert J.W., Hauser T., Luqmani R., Morgan M.D., Peh C.A., et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010, 363(3):211-220.
53. Rutgers A., Kallenberg C.G.M. Refractory vasculitis. Autoimmun Rev 2011 Sep, 10(11):702-706.
54. Chan A.T., Floßmann O., Mukhtyar C., Jayne D.R.W., Luqmani R.A. The role of biologic therapies in the management of systemic vasculitis. Autoimmun Rev 2006, 5:273-278.
55. Hu W., Liu C., Xie H., Chen H., Liu Z., Li L. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transplant 2008, 23(4):1307-1312.
56. Silva F., Specks U., Kalra S., Hogan M.C., Leung N., Sethi S., et al. Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement - a prospective, open-label pilot trial. Clin J Am Soc Nephrol 2010, 5(3):445-453.
57. Han F., Liu G., Zhang X., Li X., He Q., He X., et al. Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis. Am J Nephrol 2011, 33(2):185-192.
58. Remuzzi G., Perico N., Macia M., Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005, 99:S57-S65.
59. Ruggenenti P., Perticucci E., Cravedi P., Gambara V., Costantini M., Sharma S.K., et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008, 19(6):1213-1224.